JP2002526410A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526410A5
JP2002526410A5 JP2000573362A JP2000573362A JP2002526410A5 JP 2002526410 A5 JP2002526410 A5 JP 2002526410A5 JP 2000573362 A JP2000573362 A JP 2000573362A JP 2000573362 A JP2000573362 A JP 2000573362A JP 2002526410 A5 JP2002526410 A5 JP 2002526410A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylcarbamoyl
cyano
hydrogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000573362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002526410A (ja
Filing date
Publication date
Priority claimed from GBGB9821703.7A external-priority patent/GB9821703D0/en
Priority claimed from GBGB9905238.3A external-priority patent/GB9905238D0/en
Application filed filed Critical
Priority claimed from PCT/GB1999/003273 external-priority patent/WO2000020003A1/en
Publication of JP2002526410A publication Critical patent/JP2002526410A/ja
Publication of JP2002526410A5 publication Critical patent/JP2002526410A5/ja
Pending legal-status Critical Current

Links

JP2000573362A 1998-10-07 1999-10-04 タキキニン受容体拮抗剤としてのナフタレンカルボキシアミド Pending JP2002526410A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9821703.7 1998-10-07
GBGB9821703.7A GB9821703D0 (en) 1998-10-07 1998-10-07 Compounds
GBGB9905238.3A GB9905238D0 (en) 1999-03-09 1999-03-09 Compounds
GB9905238.3 1999-03-09
PCT/GB1999/003273 WO2000020003A1 (en) 1998-10-07 1999-10-04 Naphthalenecarboxamides as tachykinin receptor antagonists

Publications (2)

Publication Number Publication Date
JP2002526410A JP2002526410A (ja) 2002-08-20
JP2002526410A5 true JP2002526410A5 (https=) 2006-11-24

Family

ID=26314462

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000573362A Pending JP2002526410A (ja) 1998-10-07 1999-10-04 タキキニン受容体拮抗剤としてのナフタレンカルボキシアミド

Country Status (15)

Country Link
US (1) US6500818B1 (https=)
EP (1) EP1119355B1 (https=)
JP (1) JP2002526410A (https=)
KR (1) KR20010099674A (https=)
CN (1) CN1322134A (https=)
AT (1) ATE230598T1 (https=)
AU (1) AU6111099A (https=)
BR (1) BR9914333A (https=)
CA (1) CA2344807A1 (https=)
DE (1) DE69904847T2 (https=)
GB (1) GB9922519D0 (https=)
ID (1) ID25749A (https=)
IL (1) IL142048A0 (https=)
NO (1) NO20011766L (https=)
WO (1) WO2000020003A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846814B2 (en) 2000-04-06 2005-01-25 Astra Zeneca Ab Neurokinin antagonists for use as medicaments
EP1278719B1 (en) * 2000-04-06 2005-11-02 AstraZeneca AB Naphthamide neurokinin antagonists for use as medicaments
US6903092B2 (en) 2000-04-06 2005-06-07 Peter Bernstein Naphthamide neurokinin antagonists for use as medicaments
DE60134735D1 (de) * 2000-04-06 2008-08-21 Astrazeneca Ab Neue neurokinin-antagonisten zum gebrauch als arzneimittel
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence
SE0004827D0 (sv) * 2000-12-22 2000-12-22 Astrazeneca Ab Therapeutic compounds
SE0103795D0 (sv) * 2001-11-02 2001-11-02 Astrazeneca Ab Compounds and method for the treatment of överactive bladder
SE0103668D0 (sv) * 2001-11-02 2001-11-02 Astrazeneca Ab Method for the treatment of overactive blader
SE0201938D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New process
FR2853648B1 (fr) * 2003-04-11 2006-08-18 Fournier Lab Sa Nouveaux derives de benzenesulfonamides et leur utilisation en therapeutique
TW200508221A (en) 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
SE0403005D0 (sv) * 2004-12-09 2004-12-09 Astrazeneca Ab New use
US20100069346A1 (en) * 2005-06-23 2010-03-18 Sara Holmqvist New Azetidine Derivatives as Neurokinin Receptor Antagonists for the Treatment of Gastrointestinal Diseases
JP2008546768A (ja) * 2005-06-23 2008-12-25 アストラゼネカ・アクチエボラーグ 胃腸疾患を治療するためのニューロキニン受容体アンタゴニストとしての新規なアゼチジン誘導体
AR056087A1 (es) * 2005-09-29 2007-09-19 Astrazeneca Ab Derivados de azetidina como antagonistas de receptores de neuroquina nk
AR057828A1 (es) 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
AU2007211475A1 (en) * 2006-02-01 2007-08-09 Solvay Pharmaceuticals Gmbh Novel dual NK2/NK3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
US8106208B2 (en) 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
WO2010048302A1 (en) 2008-10-21 2010-04-29 Oregon Health & Science University Naphthamides as anticancer agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97540C (fi) 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
IL99320A (en) 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
GB9310713D0 (en) 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles

Similar Documents

Publication Publication Date Title
JP2002526410A5 (https=)
CN1134417C (zh) 3-苯基吡啶衍生物及其作为nk-1受体拮抗剂的应用
US8980905B2 (en) Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
JP2004517099A5 (https=)
JP2002520316A5 (https=)
JP2000159749A5 (https=)
JP2005523254A5 (https=)
TW200628472A (en) Piperidinylamino-thieno (2,3-d) pyrimidine compounds
EP2592070A3 (en) Tetrazole-substituted arylamides
JP2009523760A5 (https=)
JP2004520324A5 (https=)
JP2008540554A5 (https=)
JP2000501728A (ja) タキキニン受容体の拮抗薬としての3―ベンジルアミノピロリジン及び3―ベンジルアミノピペリジン
TW200716520A (en) 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
JP2004507527A5 (https=)
JP2009538873A5 (https=)
JP2007520440A5 (https=)
JP2004517130A5 (https=)
JP2005527542A5 (https=)
JP2005521651A5 (https=)
JP2004509954A5 (https=)
JP2002526527A5 (https=)
JP2002531548A5 (https=)
DE602005022572D1 (de) Antagonisten des opioidrezeptors